Vilin Bio Med Ltd.

NSE: VILINBIO

Vilin Bio Med Live Share Price Today, Share Analysis and Chart

Name: Vilin Bio Med Ltd.: Is Infosys Ltd. worth buying?
Item: Vilin Bio Med Ltd.
Rating: 2.00458325
Author: Trendlyne DVM scores

aboutVilin Bio Med Ltd. is a domestic pharmaceutical company primarily involved in the manufacturing and trading of pharmaceutical products. The company focuses on the development of generic formulations across multiple therapeutic segments and operates w... Read More

-1.40(-2.57%)

180.47% Gain from 52W Low

8,000

NSE Volume

NSE 03 Nov, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

- / 100

56.9 / 100

No estimates available

SWOT Analysis

Check Before You Buy

VIEW FULL CHECKLIST

High rank

9Positive9Negative

50.0%Pass in checklist

045

100

Check P/E Buy Sell Zone

Buy Zone

38.0 % into P/E buy sell zone

% time spent below current P/E

020406080100

Strong upside potential

Gains already realized

Vilin Bio Med Stock Price Analysis

Day Price Range -2.6% 1 Day return	53.2 (LTP) 51.855 LowHigh
Week Price Range 4.4% 1 Week return	53.2 (LTP) 48.455 LowHigh
Month Price Range -5.9% 1 Month return	53.2 (LTP) 48.157 LowHigh
52 Week Price Range 101.0% 1 Year return	53.2 (LTP) 1961 LowHigh

View full Price History/Seasonality

Competitors/Peers

Annual

Balance Sheet

Ratios

Cash Flow

Documents

Vilin Bio Med annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Vilin Bio Med Mar-2026 Annual Revenue is Rs 42 Cr which is growth of 176.6% YoY.
POSITIVE
Annual Net Profit Vilin Bio Med Mar-2026 Annual Net Profit is Rs 2 Cr which is growth of 763.0% YoY.

Vilin Bio Med Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20
SR_A Total Rev. Ann. ⌄	50.9%	29.3%	42.3	15.3	16.1	12.3	11.2	11.7	16.8
TotalOperatingRevenues_A Operating Rev. Ann.	50.9%	29.3%	42.3	14.8	15.8	12.3	11.2	11.7	16.8
OI_A Other Income Ann.	-	-		0.5	0.3	0			0
OEXPNS_A Operating Exp. Ann.	59.1%	29.1%	39.1	14	15	9.7	10.5	10.9	15.9
OEXPNS_A Operating Exp. Ann.	59.1%	29.1%	39.1	14	15	9.7	10.5	10.9	15.9
OP_A Operating Profit Ann.	7.2%	28.9%	3.2	0.8	0.8	2.6	0.8	0.9	0.9
OPMPCT_A OPM Ann. %	-28.7%	0.7%	7.56%	5.15%	5.06%	20.86%	6.83%	7.31%	5.34%
TotalExpenses_A Total Exp. Ann. ⌄	54.9%	27.7%	39.4	15	15.9	10.6	11.2	11.6	16.6
OtherExpenses_A Other Exp. Ann.	-25.6%	7%	0.7	0.3	1.2	1.7	0.4	0.5	0.6
EmployeeBenefitExpenses_A Employee Exp. Ann.	-4.4%	-8.6%	0.7	0.3	0.8	0.8	1	1.1	1.4
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-	-
CostOfFuel_A Cost Of Fuel Ann.	-	-
EBIDT_A EBITDA Ann.	7.2%	28.9%	3.2	1.3	1.1	2.6	0.8	0.9	0.9
EBIDTPCT_A EBITDA Ann. margin %	-28.9%	0.6%	7.56%	8.22%	7.07%	21.06%	6.86%	7.34%	5.41%
INT_A Interest Ann.	-47.7%	-24.2%	0.1	0.9	0.8	0.7	0.5	0.4	0.4
DEP_A Depr.	14.5%	0%	0.3	0.1	0.1	0.2	0.2	0.3	0.3
PBT_A PBT Ann.	15.9%	69.5%	2.8	0.3	0.2	1.8	0	0.2	0.2
TAX_A Tax Ann.	21.6%	-	0.9	0.1	0.1	0.5	0	0	0
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	16.6%	80.2%	1.9	0.2	0.2	1.2	0	0.1	0.2
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-	-	-	-	-	-	-	-
NP_A Net Profit Ann.	16.6%	80.2%	1.9	0.2	0.2	1.2	0	0.1	0.2
NETPCT_A NPM Ann. %	-23.3%	34.7%	4.56%	1.50%	1.02%	10.11%	0.29%	1.03%	0.96%
EPS_adj_A EPS Adj. latest Ann.	17.6%	67%	1.3	0.2	0.1	0.8	0	0.1	0.1

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

VIEW ALL TABLE IN FINANCIAL PAGE

Total Rev. Ann.

1Y CHG

176.5%

2Y CAGR

62.1%

3Y CAGR

50.9%

5Y CAGR

29.3%

Net Profit Ann.

1Y CHG

850%

2Y CAGR

208.2%

3Y CAGR

16.6%

5Y CAGR

80.2%

Operating Exp. Ann.

1Y CHG

179.3%

2Y CAGR

61.5%

3Y CAGR

59.1%

5Y CAGR

29.1%

Vilin Bio Med Technical Analysis

Vilin Bio Med EMA & SMA

Bullish+8

8 bullish, 0 bearish

Bullish8

Bearish0

5 Day	52.7
10 Day	52.4
12 Day	52.4
20 Day	52.5

26 Day	52.4
50 Day	51.2
100 Day	47.8
200 Day	41.9

Vilin Bio Med Delivery And Volume

Daily Avg. Delivery Volume %

03 Nov, 2026100.0%

Week85.7%

Month92.3%

Vilin Bio Med Active Candlesticks

Dark Cloud Cover

Legend

Positive IndicatorNeutral IndicatorNegative Indicator

Vilin Bio Med Resistance and Support

53.33

Pivot

First Resistance	54.8
Second Resistance	56.5
Third Resistance	58.0

First Support	51.7
Second Support	50.2
Third Support	48.5

Day RSI	52
Day MACD	0
Day MFI	29.6
Day MACD Signal Line	0

Vilin Bio Med Beta

1 Month	0.3
1 Year	0.4

3 Month	-0.1
3 Year	-

Vilin Bio Med Price Change Analysis

↓-5.9%

Over 1 Month

LowHigh

48.157

↑32.9%

Over 3 Months

LowHigh

39.961.0

↑36.8%

Over 6 Months

LowHigh

38.661.0

↑101.0%

Over 1 Year

LowHigh

19.061.0

Vilin Bio Med Shareholding Pattern/ Ownership

Shareholding Summary

Sep 2026

Name	Category	Shares	Shares %
Sharaz Shaik	Promoter	1,831,979	12.0 %
Enspire Institute Of Professional Studies Llp	Public	670,000	4.4 %

HISTORICAL PROMOTER HOLDING

Promoters holding remains unchanged at 56.65% in Sep 2026 qtr

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

All Shareholding details

Vilin Bio Med Deals - Insider, Bulk, Block and SAST

Client Name	Deal Type	Action	Date	Avg. Price	Quantity	Exchange
KASHINATH SAHU	Bulk	Sell	30 Jul 2025	26.25	76,000	NSE
KASHINATH SAHU	Bulk	Sell	12 Jun 2025	27.85	72,000	NSE
MANISH UPENDRA SHANGHVI	Bulk	Sell	20 Jan 2025	22.31	88,000	NSE
MOHAN RAO ADHI	Bulk	Sell	16 Oct 2024	20	4,000	NSE
MOHAN RAO ADHI	Bulk	Purchase	16 Oct 2024	23.35	96,000	NSE
K MURALIDHAR REDDY	Bulk	Sell	27 Mar 2024	18.74	100,000	NSE
RIKHAV SECURITIES LIMITED	Bulk	Sell	01 Feb 2024	22.33	180,000	NSE
JITENDRA RASIKLAL SANGHAVI	Bulk	Purchase	01 Feb 2024	22.76	104,000	NSE
RIKHAV SECURITIES LIMITED	Bulk	Purchase	01 Feb 2024	26.50	4,000	NSE
MANISH UPENDRA SHANGHVI	Bulk	Purchase	01 Feb 2024	22.54	88,000	NSE

All deals

All insider trades

Vilin Bio Med Corporate Actions

Vilin Bio Med Board Meetings

Vilin Bio Med past and upcoming board meetings.

#Ex-Date	Purpose	Notes
118 Sep 2026	Other business matters	-
230 May 2026	Audited Results	-
316 Feb 2026	Others	(Revised) To consider other business matters - proposed Scheme of Merger/Amalgamation.
410 Jan 2026	Fund Raising & Others	To consider other business matters.
512 Nov 2025	Quarterly Results	-

All Corporate Actions

Vilin Bio Med - Company Profile

Vilin Bio Med Management Structure

Vilin Bio Med management structure with salaries, total experience, and qualifications.

NAME	DESIGNATION	GROSS REMUNERATION ₹(LAC)	AS OF	HISTORY & DETAILS
Ms. Pallapu Shivani	Chief Financial Officer	-	Mar 26
Neha Lahoti	Company Secretary,Compliance Officer	-	Mar 26

Vilin Bio Med Board of Directors

Vilin Bio Med Board of directors with salaries, total experience, and qualifications.

NAME	POSITION	GROSS REMUNERATION ₹(LAC)	AS OF
MADHUSUDHAN YADAMAKANTI REDDY	Managing Director	-	Mar 25
PRASANNA LAKSHMI VENNA	Whole-time Director	-	Mar 25
S Viswa Prasad	Whole-time Director	-	Mar 25
SASIKANTH PARITALA	Independent Non Exe. Director	-	Mar 25
VEERAIAH CHOWDARY KOLLA	Independent Non Exe. Director	-	Mar 25
GIRISH GIRISH MUKTEVI	Independent Non Exe. Director	-	Mar 25
Dhruv Vishwanath Todi.	Company Sec. & Compli. Officer	-	Mar 25

About

Website: www.vilinbiomed.co.in

About the company - Business Profile

Vilin Bio Med Ltd. is a domestic pharmaceutical company primarily involved in the manufacturing and trading of pharmaceutical products. The company focuses on the development of generic formulations across multiple therapeutic segments and operates within the broader healthcare industry.

Key Points

Key Facts: Vilin Bio Med Ltd. was incorporated in 2005 and is headquartered in Hyderabad, Telangana. The company is listed on the BSE SME platform. It operates as a manufacturer and trader of bulk drugs and pharmaceutical formulations.
Operations and Resources: The company maintains manufacturing facilities compliant with local regulatory standards for oral solids and other dosage forms. Its core operational strength lies in the integration of its manufacturing capabilities with a distribution network focused on the domestic Indian market.
Ownership: The company is a publicly listed entity. As of recent filings, the promoter group maintains a significant stake, with the remaining shares held by the public and retail investors.
Market and Significance: Vilin Bio Med serves the pharmaceutical and healthcare sectors. It provides cost-effective generic alternatives in therapeutic areas such as anti-infectives, analgesics, and nutritional supplements, contributing to the accessibility of essential medicines.
Business Model: The company’s business model is built on contract manufacturing and the distribution of its own branded generics. It specializes in the formulation of finished dosage forms (FDFs), leveraging its manufacturing assets to cater to both direct market sales and third-party manufacturing requirements.
Revenue Breakdown: For the financial year ended March 31, 2025:
- Revenue from Operations: ₹11.24 Crore (Annual FY25).
- Net Profit/Loss: The company reported a Profit After Tax (PAT) of ₹0.42 Crore for FY25.
- Geographical Concentration: Significant revenue (over 90%) is derived from the Domestic (Indian) market, with minimal exposure to direct exports.
Key Products and Technology:
- The product portfolio includes tablets, capsules, and syrups.
- Key therapeutic categories: Gastrointestinal, Cardiovascular, and Anti-diabetic formulations.
- The company focuses on process optimization in its formulation development to maintain price competitiveness in the generic market.
Strategic Initiatives: Current focus areas include the expansion of the product pipeline in the chronic disease segment and enhancing production capacity to support increased contract manufacturing orders.

References

Vilin Bio Med FAQ

Vilin Bio Med today is trading in the red, down by 2.57% at ₹53.15.

Vilin Bio Med is currently trading down 2.57% on an intraday basis. In the past week the stock rose 4.42%. Stock has been up 32.88% in the past quarter and rose 100.95% in the past year. You can view this in the share price history/seasonality section.

Vilin Bio Med is listed on NSE with the ticker VILINBIO. It's currently trading on NSE at a share price of ₹53.15.

The market cap of Vilin Bio Med is ₹81.05 Cr. as of Nov 03, 2026.

Vilin Bio Med has never announced any dividend since the time of its listing on the NSE exchange.

Vilin Bio Med has never issued stock splits or bonus shares since the time of its listing on the NSE exchange.

Vilin Bio Med reported ₹42.26 Cr. in revenue, ₹1.93 Cr. in net profit, and ₹3.19 Cr. in EBITD as of Mar 31, 2026 for FY25-26.

There are no analyst predictions for stock price target for Vilin Bio Med.

The PE ratio of Vilin Bio Med is 42.02 as of Nov 03, 2026.

The PB ratio of Vilin Bio Med is 2.86 as of Nov 03, 2026.

There are no analyst reports for Vilin Bio Med.

You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.

Key Metrics
DVM
Price Chart
Forecaster
Financials
Technicals
Shareholding
Deals
Documents
Corporate actions
Company Profile

Vilin Bio Med Live Share Price Today, Share Analysis and Chart

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Vilin Bio Med Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

Vilin Bio Med - Annual

Vilin Bio Med annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Annual Revenue Vilin Bio Med Mar-2026 Annual Revenue is Rs 42 Cr which is growth of 176.6% YoY.

Annual Net Profit Vilin Bio Med Mar-2026 Annual Net Profit is Rs 2 Cr which is growth of 763.0% YoY.

Vilin Bio Med Technical Analysis

Vilin Bio Med EMA & SMA

Vilin Bio Med Delivery And Volume

Vilin Bio Med Active Candlesticks

Vilin Bio Med Resistance and Support

Vilin Bio Med Beta

Vilin Bio Med Price Change Analysis

Vilin Bio Med Shareholding Pattern/ Ownership

Shareholding Summary

HISTORICAL PROMOTER HOLDING

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

Vilin Bio Med Deals - Insider, Bulk, Block and SAST

Bulk Block Deals

Insider Trading & SAST

Vilin Bio Med Corporate Actions

Vilin Bio Med Board Meetings

Vilin Bio Med past and upcoming board meetings.

Vilin Bio Med - Company Profile

Vilin Bio Med Management Structure

Vilin Bio Med management structure with salaries, total experience, and qualifications.

Vilin Bio Med Board of Directors

Vilin Bio Med Board of directors with salaries, total experience, and qualifications.

About the company - Business Profile

Key Points

Vilin Bio Med FAQ

How is Vilin Bio Med today?

Vilin Bio Med today is trading in the red, down by 2.57% at ₹53.15.

How has Vilin Bio Med performed historically?

Vilin Bio Med is currently trading down 2.57% on an intraday basis. In the past week the stock rose 4.42%. Stock has been up 32.88% in the past quarter and rose 100.95% in the past year. You can view this in the share price history/seasonality section.

What is the current share price of Vilin Bio Med on NSE and BSE exchanges?

Vilin Bio Med is listed on NSE with the ticker VILINBIO. It's currently trading on NSE at a share price of ₹53.15.

What is the market cap of Vilin Bio Med?

The market cap of Vilin Bio Med is ₹81.05 Cr. as of Nov 03, 2026.

When did Vilin Bio Med last pay a dividend, and what has its dividend history been?

Vilin Bio Med has never announced any dividend since the time of its listing on the NSE exchange.

Has Vilin Bio Med issued any bonus shares or share splits recently?

Vilin Bio Med has never issued stock splits or bonus shares since the time of its listing on the NSE exchange.

What do the financial statements and annual reports of Vilin Bio Med Indicate?

Vilin Bio Med reported ₹42.26 Cr. in revenue, ₹1.93 Cr. in net profit, and ₹3.19 Cr. in EBITD as of Mar 31, 2026 for FY25-26.

What is the target share price of Vilin Bio Med according to analyst predictions in FY26-27?

There are no analyst predictions for stock price target for Vilin Bio Med.

What is the PE Ratio of Vilin Bio Med?

The PE ratio of Vilin Bio Med is 42.02 as of Nov 03, 2026.

What is the PB Ratio of Vilin Bio Med?

The PB ratio of Vilin Bio Med is 2.86 as of Nov 03, 2026.

Where can I check the latest Research Reports about Vilin Bio Med?

There are no analyst reports for Vilin Bio Med.

How can I be notified of real time alerts about Vilin Bio Med stock?

You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.